Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Adjuvant in Pediatric Moderate Persistent Asthma
NCT06869798Phase 3Completed
- Sponsor
- King Edward Medical University
- Start
- Sep 2021
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zinc in asthma, sponsored by King Edward Medical University. Started Sep 2021; status: completed.
02
Drugs
zinc
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06869798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06869798.